Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

StemCells pares 4Q loss after acquisition
Yahoo/AP
Thursday, March 11, 2010 - 9:01am
tags:
earnings, StemCells
10 Biotech Stocks On the Line
TheStreet.com
Thursday, March 11, 2010 - 8:57am
tags:
Medivation, InterMune, Allos, Affymax, Amylin, Alkermes, Cell Therapeutics, Delcath, Dendreon, GenVec, MannKind, Somaxon, Vertex Pharmaceuticals
Merck’s Stromectol Wipes Out Hard-to-Treat Lice, Study Finds
Bloomberg
Thursday, March 11, 2010 - 8:54am
tags:
Merck, lice, Stromectol
At Novartis, It's Pregnant Women vs. Cheerleaders Among the Sales Reps
BNET Pharma
Thursday, March 11, 2010 - 8:53am
tags:
sales reps, discrimination, Novartis, cafepharma
Did J&J Plan to Break Rules?
Businessweek
Thursday, March 11, 2010 - 8:51am
tags:
Risperdal, JNJ
Sanofi-aventis Successfully Completes The Acquisition of Chattem, Inc
Yahoo
Thursday, March 11, 2010 - 8:40am
tags:
Sanofi, M&A, Chattem
AstraZeneca Teams Up With India’s Torrent in Generics
Bloomberg
Thursday, March 11, 2010 - 8:37am
tags:
AstraZeneca, India, generics, Torrent Pharmaceuticals, partnerships
Drug Safety, Social Media & A Universal Symbol
Pharmalot
Thursday, March 11, 2010 - 8:36am
tags:
social media, drug safety, PhRMA
Obamacare? Who Cares? There Are Drug Deals To Do
WSJ Online
Thursday, March 11, 2010 - 8:32am
tags:
healthcare reform, M&A, Abbott Laboratories, Facet Biotech, Astellas, OSI Pharmaceuticals, Pfizer, Teva Pharmaceuticals, Ratiopharm
Chelsea Therapeutics 4Q loss narrows on costs
Yahoo/AP
Thursday, March 11, 2010 - 8:30am
tags:
Chelsea Therapeutics, earnings
Nabi Biopharmaceuticals logs revenue from Glaxo sale
Bizjournals.com
Thursday, March 11, 2010 - 8:30am
tags:
GSK, Nabi, PentaStaph, licensing.NicVAx
3 Biotech Stocks On The Move
Investopedia
Wednesday, March 10, 2010 - 11:18am
tags:
OSI Pharmaceuticals, InterMune, Medivation
Biotechs Jump on Facet, Intermune Deal
Barron's
Wednesday, March 10, 2010 - 11:17am
tags:
InterMune, Facet Biotech
A Tale Of Two Sectors
CNBC
Wednesday, March 10, 2010 - 11:08am
tags:
biotech, Big Pharma
InterMune’s Lung Drug Gets Backing From FDA Panel
WSJ Online
Wednesday, March 10, 2010 - 10:46am
tags:
FDA, InterMune, pirfenidone
5-Star Stocks Poised to Pop: Teva Pharmaceutical
Motley Fool
Wednesday, March 10, 2010 - 10:12am
tags:
Teva Pharmaceuticals
Biotech VCs, Big Pharma stepping outside the comfort zone
Fierce Biotech
Wednesday, March 10, 2010 - 10:02am
tags:
venture capital
FDA grants Cytokinetics treatment orphan status
Yahoo/AP
Wednesday, March 10, 2010 - 9:34am
tags:
FDA, Cytokinetics, orphan drugs
Transgene Sells Option on Cancer Vaccine to Novartis
Bloomberg
Wednesday, March 10, 2010 - 9:24am
tags:
Novartis, Transgene, vaccines
J&J Pushed Risperdal for Elderly After U.S. Warning, Files Show
Bloomberg
Wednesday, March 10, 2010 - 9:16am
tags:
JNJ, Risperdal

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.